Riomet is intended for adults and children 10 years and older with type 2 diabetes.
Sun Pharma initiated the recall after discovering the drug contained Scopulariopsis brevicaulis, a fungus that can cause pneumonia, sinusitis and disseminated infections. Patients who take the contaminated drug product could be at risk for infection, although Sun Pharma has not received any reports of adverse events related to Riomet.
The affected product, made by a contract manufacturer, was distributed to wholesale customers nationwide. Sun Pharma notified customers of the recall and is working with them to arrange the return of all recalled products.
More articles on supply chain:
6 must-reads for supply chain leaders this week
FDA raids central Florida stores that supply patents with Canadian drugs
FDA OKs epinephrine auto-injector for children: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.